Table 3.
Controls (n=1469) |
All cases (n=1028) |
Adults (n=819) |
Children (n=36) |
Adolescents (n=102) |
Men over 50 years (n=69) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prop. | Prop. | Adjusted ORa (95% CI) |
Prop. | Adjusted ORa (95% CI) |
Prop. | Adjusted ORa (95% CI) |
Prop. | Adjusted ORa (95% CI) |
Prop. | Adjusted ORa (95% CI) |
p-valueb | ||
MTAP | |||||||||||||
rs10757257 | |||||||||||||
G (A) | 0.58 | 0.64 | 1.32 (1.14–1.53) | 0.63 | 1.32 (1.14–1.54) | 0.64 | 1.27 (0.79–2.05) | 0.63 | 1.22 (0.91–1.63) | 0.66 | 1.41 (0.99–2.02) | 0.52 | |
PLA2G6 | |||||||||||||
rs132985 | |||||||||||||
C (T) | 0.52 | 0.56 | 1.07 (0.93–1.24) | 0.56 | 1.08 (0.93–1.25) | 0.61 | 1.42 (0.87–2.32) | 0.52 | 1.00 (0.75–1.34) | 0.54 | 1.05 (0.74–1.49) | 0.23 | |
IRF4 | |||||||||||||
rs12203592 | |||||||||||||
T (C) | 0.23 | 0.20 | 1.01 (0.83–1.22) | 0.21 | 1.04 (0.85–1.27) | 0.10 | 0.35 (0.16–0.77) | 0.16 | 0.61 (0.42–0.91) | 0.22 | 0.90 (0.59–1.37) | 0.0008 | |
Naevus category | |||||||||||||
None/a few or <10 | 0.67 | 0.46 | 1.00 (Reference) | 0.49 | 1.00 (Reference) | 0.19 | 1.00 (Reference) | 0.22 | 1.00 (Reference) | 0.65 | 1.00 (Reference) | ||
Moderate or 10–50 | 0.27 | 0.41 | 2.39 (1.92–2.98) | 0.39 | 2.23 (1.78–2.80) | 0.53 | 6.55 (2.73–15.73) | 0.55 | 6.34 (3.82–10.55) | 0.28 | 1.06 (0.61–1.83) | <0.0001 | |
Many or >50 | 0.06 | 0.13 | 3.07 (2.14–4.39) | 0.12 | 2.79 (1.92–4.05) | 0.28 | 15.47 (5.70–41.97) | 0.23 | 12.30 (6.60–22.93) | 0.07 | 1.27 (0.49–3.27) | <0.0001 | |
Ptrend<0.0001 | Ptrend<0.0001 | Ptrend<0.0001 | Ptrend<0.0001 | Ptrend=0.68 |
Adjusted for ancestry score, age, number of naevi, freckling, skin colour and hair colour
Test for homogeneity in estimates across subsamples
CI: Confidence Interval; OR: Odds-Ratio